Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2021 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
April 28, 2021 07:00 ET | Source: Calithera Biosciences, Inc.

Results from Calithera Biosciences’ CANTATA Study to Be Presented at 2021 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 28, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel...
March 16, 2021 16:06 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights

--Calithera to Provide Corporate Update via Conference Call and Webcast at 2:00 p.m. PT on March 16, 2021-- SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Calithera...
March 12, 2021 15:09 ET | Source: Calithera Biosciences, Inc.

UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021

SOUTH SAN FRANCISCO, Calif., March 12, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
March 10, 2021 07:05 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021

SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
March 02, 2021 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference

SOUTH SAN FRANCISCO, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
February 22, 2021 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small...
January 11, 2021 17:03 ET | Source: Calithera Biosciences, Inc.

INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium

SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
January 05, 2021 07:04 ET | Source: Calithera Biosciences, Inc.

Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small...
January 04, 2021 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint

-- Company will continue to advance telaglenastat KEAPSAKE trial in non-small cell lung cancer, arginase inhibitor CB-280 trial in cystic fibrosis and emerging pipeline -- Company to host webcast and...